Jorge A. Belardi, MD, PhD

Intravascular Thermographic Assessment in Human Coronary Atherosclerotic Plaques by a Novel Flow-Occluding Sensing Catheter: A S

08/01/2008

Fernando A. Cura , MD;

Mariano Albertal , MD, PhD;

Lucio T. Padilla , MD;

William W. O'Neill , MD;

Jorge A. Belardi , MD, PhD;

Oscar A. Mendiz , MD;

Pablo Perez Balino , MD;

Previous studies support the concept that atherosclerosis is an inflammatory disease.1,2 Inflammation plays an important role not only in the development, but also in the acute complications of atherosclerotic plaques.3 The detection of...

Previous studies support the...

08/01/2008

Journal of Invasive Cardiology

Commentary

Preventing Restenosis with Stent Drug Coatings

08/01/2008

Kirk N. Garratt , MD, MSc;

Tim A. Fischell , MD, FACC, FSCAI;

Jorge A. Belardi , MD, PhD;

Christopher U. Cates , MD;

Philip Walker , MD;

Roberto Falotico , MD;

Uncertainties with Drug-Eluting Stents Percutaneous coronary revascularization is a worldwide accepted technique as part of the treatment of coronary artery disease. Despite the use of stents, restenosis continues to be the major limitation...

Uncertainties with Drug-Eluting...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

Distal Protection during Primary Angioplasty: A Feasibility and Safety Study Utilizing a Novel Filter Technology

08/01/2008

Fernando A. Cura , MD;

Mariano Albertal , MD, PhD;

Jose Milei , MD;

Lucio T. Padilla , MD;

Pablo Perez Bali , MD;

Marcelo Trivi , MD;

Jorge A. Belardi , MD, PhD;

William W. O'Neill , MD;

Signs of suboptimal myocardial reperfusion are frequently encountered following primary angioplasty and this phenomenon is associated with poor left ventricular wall motion recovery and unfavorable clinical outcomes.1–4 Patients with acute...

Signs of suboptimal myocardial...

08/01/2008

Journal of Invasive Cardiology

IAGS (International Andreas Gruentzig Society) Proceedings

9th Biennial International Andreas Gruentzig Society: New Developments in Gene
Therapy and Stem Cells for Angiogenesis in the

08/01/2008

Jorge A. Belardi , MD, PhD;

Joseph D. Babb , MD;

Sigrid Nikol , MD;

William W. O'Neill , MD;

Robert Simari , MD;

Timothy D. Henry , MD;

Prof. Dr. Sigrid Nikol MD: I welcome you to this session, New Developments in Gene Therapy and Stem Cells for Angiogenesis in the Treatment of Myocardial Infarction. Initial developments of regenerative therapies were mainly angiogenesis...

Prof. Dr. Sigrid Nikol MD: I...

08/01/2008

Journal of Invasive Cardiology

IAGS (International Andreas Gruentzig Society) Proceedings

Drug-Eluting Stents: Current Limitations

08/01/2008

Jamey Jacobs ;

Tim A. Fischell , MD, FACC, FSCAI;

Jorge A. Belardi , MD, PhD;

Christopher U. Cates , MD;

Alfredo E. Rodriguez , MD, PhD;

Gregory Braden , MD;

Mike Cowley , MD;

David Sperling , MD;

Robert Fischell , MD;

Mike Cowley: Let’s begin with discussing case selection. Which patients should receive drug-eluting stents (DES)? Should they only receive one stent? Should we reserve DES for a select patient population? What should the approach be for...

Mike Cowley: Let’s begin with...

08/01/2008

Journal of Invasive Cardiology

IAGS (International Andreas Gruentzig Society) Proceedings

Microvascular Disease and Injury: Prevention and Therapies

08/01/2008

Pierre Leimgruber , MD;

Jeffrey Werner , MD;

Philip Reid ;

Kenneth M. Kent , MD, PhD;

Richard R. Heuser , MD, FACC, FACP, FESC, FSCAI;

Jorge A. Belardi , MD, PhD;

Howard A. Cohen , MD;

Tim Fischell: Many centers have spent a lot of money on the 25 or so different distal protection devices available today. We are currently preparing a manuscript on a slightly different, simpler, and considerably less expensive approach to...

Tim Fischell: Many centers have...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

Three-Year Outcomes of Percutaneous Coronary Intervention With Next-Generation Zotarolimus-Eluting Stents for De Novo Coronary Bifurcation Lesions

11/26/2014

Franz-Josef Neumann , MD;

Ran Kornowski , MD;

Miroslaw Ferenc , MD;

Stephan Windecker , MD;

Sigmund Silber , MD;

Jorge A. Belardi , MD, PhD;

Petr Widimsky , MD;

Patrick W. Serruys , MD, PhD;

We investigate the outcomes of percutaneous coronary intervention (PCI) in bifurcation versus non-bifurcation lesions using the next-generation Resolute zotarolimus-eluting stent. There was an increased risk associated with bifurcation...

We investigate the outcomes of...

11/26/2014

Journal of Invasive Cardiology